What did the DCCT study conclude about intensive control of blood sugar in patients with type 1 diabetes and T2D?
The DCCT study concluded that intensive control of blood sugar for patients with both type 1 diabetes and T2D had been shown to reduce risk for microvascular complications, including retinopathy, nephropathy, and peripheral neuropathy. The findings were confirmed for patients with T2D in the UKPDS, however, intensive control was associated with increased risk for hypoglycemia.